Compare LAB & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LAB | AWP |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | 389 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.2M | 348.9M |
| IPO Year | 2008 | 2007 |
| Metric | LAB | AWP |
|---|---|---|
| Price | $0.83 | $12.23 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.35 | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 202.0K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.48% |
| EPS Growth | ★ 61.54 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $101,937,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.63 | N/A |
| P/E Ratio | $2.65 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.70 | $3.78 |
| 52 Week High | $1.72 | $12.71 |
| Indicator | LAB | AWP |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 61.32 |
| Support Level | $0.79 | $11.77 |
| Resistance Level | $1.01 | $12.71 |
| Average True Range (ATR) | 0.07 | 0.13 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 30.41 | 74.00 |
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.